Biological & Pharmaceutical Bulletin 1998-11-01

Prevention of co-elution of steroid sulfates with serum proteins from pre-column in column-switching HPLC system.

N Tagawa, H Tsuruta, A Fujinami, Y Kobayashi

Index: Biol. Pharm. Bull. 21(11) , 1211-4, (1998)

Full Text: HTML

Abstract

A method to prevent co-elution of steroid sulfates with proteins in serum from the pre-column in column-switching HPLC was developed. The pre-column, a polymer-coated mixed function column, was used for ion-pair chromatography with 5 mM tetra-n-butylammonium (TBA) ion. As steroid sulfates, estriol 3-sulfate, dehydroepiandrosterone 3-sulfate and pregnenolone 3-sulfate were used. Human serum (25 microl) was diluted with mobile phases including 5, 100 and 500 mM TBA ion, and then injected directly into the pre-column. The peak areas of the steroid sulfates in serum samples were compared with those of the steroid standards without serum. When 25/microl of serum was diluted with mobile phase including 100 or 500 mM TBA ion, the steroid sulfates in serum were retained in the pre-column; however, the steroid sulfates from the same sample diluted with mobile phase containing 5 mM TBA ion were not retained in the pre-column. Addition of an excess amount of counter ion (TBA ion) into the serum sample made it possible to retain the steroid sulfates in the pre-column. This method was applied to column-switching HPLC for measurement of steroid sulfates in serum using a semi-microcolumn as the analytical column.

Related Compounds

Structure Name/CAS No. Articles
Estra-1,3,5(10)-triene-3,16,17-triol,3-(hydrogen sulfate), sodium salt (1:1), (16a,17b)- Structure Estra-1,3,5(10)-triene-3,16,17-triol,3-(hydrogen sulfate), sodium salt (1:1), (16a,17b)-
CAS:5150-64-1